with the related transaction documents, the WF-1 Facility, with Wells Fargo, as buyer, to finance the acquisition and origination of commercial real estate whole loans or senior controlling participation interests in such loans. The maximum amount of financing available under the WF-1 Facility as of June 30, 2021 is $100,000,000 which may be increased to $200,000,000 with the consent of Wells Fargo. Each transaction under the WF-1 Facility has its own specific terms, such as identification of the assets subject to the transaction, sale price, repurchase price and rate. On July 30, 2021, the WF-1 Repurchase Agreement was amended to, among other things, (i) increase the maximum amount of financing available from $200,000,000 to $350,000,000, with the option to increase, with the consent of Wells Fargo, or reduce the maximum facility amount within the range of $150,000,000 to $350,000,000, (ii) extend the funding period and maturity date from August 30, 2021 to August 30, 2022, with the option to extend the funding period for one additional year and the maturity date for three additional one-year terms with the consent of Wells Fargo, and (iii) modify the applicability of the facility debt yield test.
We incurred $1,691,934 of deferred financing costs related to the WF-1 Facility, which is being amortized to interest expense over the life of the WF-1 Facility. As of June 30, 2021, $159,748 had yet to be amortized to interest expense.
GS-1 Facility
On January 26, 2018, our indirect wholly owned, special-purpose financing subsidiary, GS-1, as seller, entered into an Uncommitted Master Repurchase and Securities Contract Agreement, or as amended, the GS-1 Repurchase Agreement, and together with the related transaction documents, the GS-1 Facility, with Goldman Sachs, as buyer, to finance the acquisition and origination of whole, performing senior commercial or multifamily floating-rate mortgage loans secured by first liens on office, retail, industrial, hospitality, multifamily or other commercial properties. The maximum amount of financing available under the GS-1 Facility as of June 30, 2021 is $175,000,000, which may be increased to $250,000,000 with the consent of Goldman Sachs if we meet certain equity capital thresholds. Each transaction under the GS-1 Facility has its own specific terms, such as identification of the assets subject to the transaction, sale price, repurchase price and rate.
The initial availability period of the GS-1 Facility (during which financing under the GS-1 Facility was available for acquisition and origination of new assets) was two years. On February 18, 2020, the GS-1 Repurchase Agreement was amended to extend the availability period to January 26, 2021, and on January 25, 2021, the GS-1 Repurchase Agreement was amended to extend the availability period to January 26, 2022. After the end of the availability period, GS-1 may exercise an option to commence a one-year amortization period, so long as certain conditions are met. During the amortization period, certain changes to the terms of the GS-1 Facility would apply, including an increase to the rate charged on each asset financed under the GS-1 Facility.
We incurred $2,690,048 of deferred financing costs related to the GS-1 Facility, which is being amortized to interest expense over the life of the GS-1 Facility. As of June 30, 2021, $389,793 had yet to be amortized to interest expense.
BB-1 Facility
On February 22, 2021, our indirect wholly owned, special-purpose financing subsidiary, FS CREIT Finance BB-1 LLC, or BB-1, entered into a Master Repurchase Agreement, or together with the related transaction documents, the BB-1 Facility, as seller, with Barclays Bank PLC, or Barclays, as purchaser, to finance the acquisition and origination of whole, performing senior commercial or multifamily floating-rate mortgage loans secured by first liens on office, retail, industrial, hospitality, multifamily, self-storage and manufactured housing property (or a combination of the foregoing, including associated parking structures). The initial maximum amount of financing available under the BB-1 Facility was $175,000,000, which was subject to increase, with the consent of Barclays, up to $250,000,000. BB-1, with the consent of Barclays, elected to increase the maximum amount of financing available, in accordance with the terms of the BB-1 Facility, on August 5, 2021, to $450,000,000. Each transaction under the BB-1 Facility will have its own specific terms, such as identification of the assets subject to the transaction, sale price, repurchase price and rate.
131